• SENSEX 80,242.24
    -46.14 (--0.06%)
  • BANKNIFTY 55,391.25
    -41.55 (--0.07%)
  • Reliance Industr
    1,411.85 1,608.95(%)
  • Mazagon Dock
    3,149.70 3,047.00(%)
  • Bajaj Finance
    8,560.00 6,376.55(%)
  • Garden Reach Sh.
    1,855.00 890.05(%)
  • Cochin Shipyard
    1,575.50 1,169.00(%)
  • Tata Motors
    641.10 542.55(%)
  • Hind.Aeronautics
    4,466.00 3,045.95(%)
  • Paras Defence
    1,469.00 1,592.75(%)
  • Torrent Pharma.
    3,300.00 2,513.05(%)
  • Sonata Software
    446.50 762.00(%)
  • Data Pattern
    2,450.00 1,350.50(%)
  • IndusInd Bank
    843.10 1,550.00(%)
  • Samvardh. Mothe.
    131.75 107.30(%)
  • Bharat Electron
    312.50 221.00(%)
  • Trent
    5,130.00 4,058.45(%)
  • Varun Beverages
    507.45 419.40(%)
  • ICICI Bank
    1,415.10 1,051.50(%)
  • Vedanta
    423.20 527.00(%)
  • Hitachi Energy
    14,879.00 16,534.50(%)
  • Tech Mahindra
    1,510.60 1,807.40(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Ortin Global Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 17472.0
  • ISIN : INE749B01020
10.52 -1 (-5.05%)
  • As on 30 Apr 2025 (EOD)

  • Today’s Low

    10.52

  • Today’s High

    11.54

  • Open

    11.15

  • Perv Close

    11.08

  • 52W Low

    9.64

  • 52W High

    24.82

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    8.55

  • Div & Yield %

    0.00

  • Book Value(₹)

    2.77

  • Debt-Equity Ratio

    -5.05

  • AGM Date

    29-Apr-2025

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    8.55

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    8.13

  • BV (₹)

    2.80

  • Sales( ₹ in Cr.)

    2.11

  • NP (in Cr.)

    -6.28

  • NP Var(%)

    -8201.0

  • Div%

    0.0

  • CPS (₹)

    -7.40

  • EPS (₹)

    -7.70

  • Traded Value (₹ in Lakhs)

    8.74

  • 52 Week High

    24.82

  • 52 Week Low

    9.64

  • Price BSE

    11.0

  • Price NSE

    11.00

  • Market Capital( in Cr.)

    8.74

  • P/C Ratio

    -1.50

  • P/E Ratio

    -1.40

  • Price Vs.BV

    -7.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 2.11 6.02 8.23 8.17 197.39 167.76
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2.11 6.02 8.23 8.17 197.39 167.76
Other Income 0.17 0.04 0.19 0.05 0.19 0.13
Stock Adjustments -1.33 0.50 -0.05 0.13 10.53 6.73
Total Income 0.95 6.56 8.37 8.35 208.11 174.62
EXPENDITURE :            
Raw Materials 2.38 3.89 4.61 4.08 165.15 141.54
Power and Fuel Cost 0.17 0.24 0.22 0.11 5.39 5.67
Employee Cost 0.48 0.68 0.74 0.85 4.72 3.68
Other Manufacturing Expenses 0.50 0.29 0.42 0.55 20.66 12.16
Selling and Administration Expenses 1.31 0.72 1.42 1.06 4.71 3.42
Miscellaneous Expenses 2.48 0.20 0.41 0.40 1.60 1.34
Employee Benefit Expenses 0.48 0.68 0.74 0.85 4.72 3.68
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 7.31 6.03 7.81 7.05 202.23 167.81
Operating Profit -6.37 0.54 0.57 1.29 5.88 6.81
Interest 0.48 0.40 0.81 0.87 3.21 3.22
Gross Profit -6.85 0.14 -0.24 0.42 2.67 3.59
Depreciation 0.23 0.25 0.29 0.29 1.96 1.75
Profit Before Tax -7.08 -0.11 -0.53 0.13 0.71 1.84
Current Tax 1.29 0.00 0.00 0.06 1.06 0.54
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.33 -0.02 -0.13 -0.87 0.23 0.02
Reported Net Profit -8.04 -0.09 -0.40 0.95 -0.56 1.28
Extraordinary Items -1.76 -0.02 0.00 0.00 -0.01 0.00
Adjusted Net Profit -6.28 -0.07 -0.40 0.95 -0.55 1.28
Adjustment below Net Profit 0.00 0.00 0.00 -4.38 -0.71 -0.26
P & L Balance brought forward 2.09 2.18 2.58 6.02 7.30 6.28
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -5.95 2.09 2.18 2.58 6.02 7.30
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.89 -0.12 -0.49 1.16 -0.33 0.76
Earnings Per Share(Adj)-Unit Curr -9.89 -0.12 -0.49 1.16 -0.33 0.76
Book Value 3.47 13.36 13.47 13.97 14.06 14.81
Book Value(Adj)-Unit Curr 3.47 13.36 13.47 13.97 14.06 14.81

Shareholding Pattern

  • Promoter Group

    1.23%

  • Public Share Holding

    98.77%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 100,300 1.23 100,300 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 100,300 1.23 100,300 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 530,728 6.53 530,728 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 530,728 6.53 530,728 2
2] Non Institution
Bodies Corporate 273,950 3.37 273,086 40
Clearing Members 432 0.01 432 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 102,401 1.26 102,401 57
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 186,084 2.29 185,604 187
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,876,544 23.08 1,876,378 28
Individuals holding nominal share capital up to Rs. 1 lakh 5,060,953 62.24 4,978,919 11,825
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,500,364 92.24 7,416,820 12,138
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,131,392 100.00 8,047,848 12,144

Company Background

Ortin Global LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Ortin Global Ltd
  • BSE Code : 17472.0
  • ISIN : INE749B01020

  • Incorporation Year

    1986

  • Registered Office

    D No 1-8-B4 Ground Floor F3
    HIG Block-4 Street No 3, Hyderabad,
    Telangana-500044

  • Telephone

  • FAX

  • Chairman

    J R K Panduranga Rao

  • Managing Director

    S Murali Krishna Murthy

  • Company Secretary

  • Auditor

    Mathesh & Ramana

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Ortin Global Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Ortin Global 10.75 2.28 2.11 -1.81 0.00
Abbott India 30,094.35 6,097.18 5,848.91 47.92 44.71
Astrazeneca Phar 8,795.90 1,330.33 1,295.53 226.76 33.26
P & G Health Ltd 5,121.00 1,166.89 1,151.26 35.93 39.76
Glaxosmi. Pharma 2,904.45 3,530.73 3,407.25 57.75 44.44
Cipla 1,541.00 17,645.00 16,574.34 26.42 20.10
Amrutanjan Healt 679.10 437.58 421.23 39.81 20.84
Guj. Themis Bio. 285.15 174.19 169.82 59.04 44.82
Fermenta Biotec. 272.25 315.24 307.09 25.81 4.10
Bliss GVS Pharma 122.65 638.96 605.46 28.07 11.19
Ambalal Sarabhai 37.10 11.70 3.81 15.85 1.92